Market Research Blog

The global regenerative medicine market is anticipated to register a phenomenal growth of 23.9% with an evaluation of around US$ 9.9 Bn by the end of the year 2022 and is further expected to enjoy an estimation of US$ 85.3 Bn by the year 2032.

Data Points	Market Insights
Market Value 2021	US$ 8.3 Bn
Market Value 2022	US$ 9.9 Bn
Market Value 2032	US$ 85.3 Bn
CAGR 2022-2032	23.9%
Market Share of Top 5 Countries	55.9%
Key Market Players	3M, Allergan plc, Amgen, Inc., Aspect Biosystems, bluebird bio, Kite Pharma, Integra LifeSciences Holdings Corporation, MEDIPOST Co., Ltd., Anterogen Co., Ltd. , MiMedx Group, Misonix, Organogenesis Inc., Orthocell Limited, Corestem, Inc., Spark Therapeutics, APAC Biotech, Shenzhen Sibiono , GeneTech Co., Ltd., Smith & Nephew plc, Stryker Corporation, Takeda Pharmaceutical Company Limited, Tego Science, Vericel Corporation, and Zimmer Biomet

According to the historical analysis done by Future Market Insights, tissue engineering by therapy type led the market growth with a share of about 43.1% in the year 2021 within the global regenerative medicine market. The targeted therapeutic market is expected to generate a revenue of around US$ 100.9 Bn by contributing about 8.3% to the global regenerative medicine market.

Regenerative medicine is widely accepted in the healthcare sector in order to counter the unmet medical needs in the field of cardiology, wound and injury musculoskeletal, oncology, dental, ophthalmology, hepatological diseases, and inflammatory & autoimmune diseases. The solutions regarding clinical and pre-clinical outcomes for allogeneic cell therapy are promising.

Request a Sample@
https://www.futuremarketinsights.com/ask-question/rep-gb-1326

Key Takeaways

• An opportunistic outlook is presented by the regenerative medicine market in the future owing to the beneficial outcomes of regenerative medicine. Several biopharmaceutical companies have initiated the establishment of regenerative medicine-specific regulatory processes which consist of guidelines, a quicker approval pathway, and also quality control for conducting clinical trials. Therefore, a massive boom in the regenerative medicine market is witnessed over the projection years.
• The industry is keeping into account some of the prominent factors such as reduced manufacturing cost, improvement in distribution systems, and expansion. Technological advances taking place in the field of life sciences date back several years ago. The gene editing technology applied in regenerative medicine manufacturing assists in yielding quality results and avoids challenges such as immune rejection.
• In order to treat a wide spectrum of diseases, pluripotent stem cell (PSC)-derived therapies are beneficial and surging rapidly over the years. These factors are acting as driving factors for the regenerative medicine market over the assessment years.
• The research and development sector is drastically making efforts to develop an innovative therapy type through modifications and implementing new discoveries in the field of cell therapy and applying gene editing tools that help in making the overall process of discovery easier. Since the methodology used is unique and determines steps for instance use of universal donor cells which establishes successful engraftment in autologous transplantation. The aforementioned factors are responsible for growth in the market.
• The growing prevalence of chronic diseases paired with the surge in wounds and injuries among the ever-growing population is anticipated to surge the regenerative medicine market. The approval of these products is governed by various regulatory laws, including pharmaceutical affairs law, technical guidance for the quality of regenerative medicine products, regulation (EC) 1394/2007, and others because these therapy types have a substantial impact on health.
• The regeneration medicine market has a direct link with the prevalence of diseases in the increasing population. Since these stem cell-based therapies have a vital impact on health thereby, the approval of these therapies including the use of regenerative medicine is governed by several standard organizations such as the Food and Drug Administration (FDA), and European Medicines Agency (EMA), among others.

Competitive Landscape

Various key players in the regeneration medicine market are focusing on expanding their consumer base in order to meet consumer demands. Since the overall market is fragmented, prominent companies in the market are implementing methods such as a divestiture, partnerships and collaborations, and new therapy launches.

Inquire Before Buying Research Report@
https://www.futuremarketinsights.com/askus/rep-gb-1326

More Insights into the Regenerative Medicine Market

The U.S. is expected to dominate the global regenerative medicine market as it is accounting for a total of about 24.2% in 2021 and is anticipated to experience a similar growth throughout the forecast period.

The account of an aging population, the widespread adoption rate of regenerative medicines, and the importance of chronic diseases are contributing factors boosting the regenerative medicine market.

Australia held a market share of around 12.9% in the global regenerative medicine market in 2021. Having a robust regulatory framework, the presence of such facilities has encouraged several ventures to invest in and look for new opportunities in Australia.

Key Market Segments Covered In Regenerative Medicine Industry Research

By Therapy type:

• Cell Therapy
  • Autologous Cell Therapy
  • Allogenic Cell Therapy
• Stem Cell Therapy
  • Allogeneic Stem Cell Therapy
  • Autologous Stem Cell Therapy
• Tissue-engineering
• Gene Therapy

By Application:

• Wound Care
• Musculoskeletal
• Oncology
• Dental
• DMD (Duchenne Muscular Dystrophy)
• Hepatological Diseases
• Inflammatory & Autoimmune Diseases
• Other Therapeutic Applications

By Region:

• North America
• Latin America
• Europe
• South Asia
• East Asia
• Oceania
• Middle East and Africa (MEA)

Read Related Reports:

https://vocal.media/stories/liquid-biopsy-market-2022-scope-of-current-and-future-industry-2031
https://degentevakana.com/blogs/view/118096
https://degentevakana.com/blogs/view/118100
https://vocal.media/stories/dental-imaging-equipment-market-2022-scope-of-current-and-future-industry-2030

About FMI                     

Future Market Insights (ESOMAR certified market research organization and a member of Greater New York Chamber of Commerce) provides in-depth insights into governing factors elevating the demand in the market. It discloses opportunities that will favor the market growth in various segments on the basis of Source, Application, Sales Channel and End Use over the next 10-years.

Contact:                                        

Future Market Insights Inc.
Christiana Corporate, 200 Continental Drive,
Suite 401, Newark, Delaware – 19713, USA
T: +1-845-579-5705
Report: https://www.futuremarketinsights.com/reports/regenerative-medicine-market
For Sales Enquiries: sales@futuremarketinsights.com
Browse latest Market Reports: https://www.futuremarketinsights.com/reports
LinkedIn| Twitter| Blogs 

FMI, an ESOMAR-certified market research firm, states that the global hospital capacity management solutions market will reach U.S$ 1.08 Bn in 2022, growing at 4.9% y-o-y in 2022.

Adoption of hospital capacity management solutions is seen amongst large patient care facilities for rendering a smooth workflow in terms of downtime as well as cost. This factor is expected to drive the hospital capacity management solutions market in the forecast period.

Request for Report Sample@
https://www.futuremarketinsights.com/reports/sample/rep-gb-1013

Key Takeaways of Hospital Capacity Management Solutions Market Study

• RTLS (Real time locating system) accounted for around 34% of hospital capacity management solutions market in 2021 and is expected to continue with being top-seeded in the forecast period
• Cloud-based hospital capacity management solution contributed for around 3/5th of market value share in 2021
• Cumulatively, North America and Europe contributed for more than 70% of the total share of the hospital capacity management solutions market in 2021
• Countries such as Brazil, China, South Africa, and India are expected to are emerging as lucrative markets, but pale in comparison to US and Europe

Expansive Prominence in the hospital capacity management solutions market

Taking the expansive way of growth helps in strengthening the solutions’ and software’s portfolio; as e-Health has picked up pace looking at the accuracy and need for data management.

• STANLEY Healthcare, in May 2022, announced the assimilation of AeroScout Real-Time Location System (RTLS) with certification from Cisco DNA Spaces. The objective of this move is to table economic solution across the healthcare industry
• Allscripts has its “2bPrecise” platform that takes in clinical information from the EHR preferred by client along with genomic/genetic data from the molecular labs, thereby giving a comprehendible patient record. This gives precise diagnoses at a faster rate.
• TeleTracking Technologies have their Capacity Management Suite with PreAdmitTracking with electronic bedboard to enable patient access as well as placement

Speak to our Research Expert@
https://www.futuremarketinsights.com/ask-question/rep-gb-1013

Want more insights?

Future Market Insights brings the comprehensive research report on forecasted revenue growth at global, regional, and country levels and provides an analysis of the latest industry trends in each of the sub-segments from 2015 to 2030. The global hospital capacity management solutions market is segmented in detail to cover every aspect of the market and present a complete market intelligence approach to the reader.

The study provide compelling insights on hospital capacity management solutions market on basis of product type (workflow management solution, asset management solution, bed management solution, quality patient care solution, real time locating system (RTLS), and event driven solutions { online registration solution, attendance management tools, event driven patient tracking, others}), application (standalone solutions, integrated solutions), delivery mode (on premise, cloud-based) across seven major regions

Read Related Reports:

https://vocal.media/stories/liquid-biopsy-market-2022-scope-of-current-and-future-industry-2031
https://degentevakana.com/blogs/view/118096
https://degentevakana.com/blogs/view/118100
https://vocal.media/stories/dental-imaging-equipment-market-2022-scope-of-current-and-future-industry-2030

About FMI                     

Future Market Insights (ESOMAR certified market research organization and a member of Greater New York Chamber of Commerce) provides in-depth insights into governing factors elevating the demand in the market. It discloses opportunities that will favor the market growth in various segments on the basis of Source, Application, Sales Channel and End Use over the next 10-years.

Contact:                                        

Future Market Insights Inc.
Christiana Corporate, 200 Continental Drive,
Suite 401, Newark, Delaware – 19713, USA
T: +1-845-579-5705
Report: https://www.futuremarketinsights.com/reports/hospital-capacity-management-solutions-market
For Sales Enquiries: sales@futuremarketinsights.com
Browse latest Market Reports: https://www.futuremarketinsights.com/reports
LinkedIn| Twitter| Blogs 

The global ophthalmic diagnostic equipment market is anticipated to showcase an opulent growth opportunity, expanding at a CAGR of 6.7% with a valuation of US$ 3.0 Bn in 2022 to US$ 5.1 Bn by 2030.

Data Points	market Insights
Market Value 2021	USD 2.9 Bn
Market Value 2022	USD 3.0 Bn
Market Value 2030	USD 5.1 Bn
CAGR 2022-2030	6.7%
Share of Top 5 Countries	57.1%
Key Players	The key players in Ophthalmic Diagnostic Equipment market are TOPCON CORPORATION, ZEISS International, Ellex, Quantel Medical, NIDEK CO., LTD., HAAG-STREIT GROUP, Halma plc, Coburn Technologies Inc., and Kowa Company Ltd.

The global ophthalmic diagnostic equipment market contributed more than 5.5% market share to the ophthalmic devices market, which was estimated to account for around USD 55.0 billion in 2021.

The market for ophthalmic diagnostic equipment is expected to surge from H1-2021 to H1-2022(O) by 44 basis point share (BPS), according to an FMI assessment. However, the growth rate comparison of the H1-2022 projected and H1-2022 outlook period showed a reduced growth rate by 10 BPS.

To Get Sample Copy of Report visit @
https://www.futuremarketinsights.com/reports/sample/rep-gb-771

Key Takeaways

• The number of individuals suffering from serious eye diseases is rising at a global level due to which loss of vision is becoming a major public health problem. As the population has increased, the prevalence of eye diseases has also surged due to the rise in chronic diseases such as diabetes and hypertension have become more common leading to issues like glaucoma or vision impairment.
• There is an increase in the number of people who are blind or have impaired vision in the upcoming years. With the rising frequency of eye disorders and the resulting increase in disability-adjusted life years (DALYs), demand for precise disease treatment is likely to increase in the future years.
• Increasing technological advancements in analytical methods help in offering improved quantification and characterization with high-resolution cross-sectional 3D images of the target tissue that is difficult to view using a conventional microscope. Owing to such high-tech equipment, the surge in the ophthalmic diagnostic equipment market can be witnessed.
• The emergence of advancement in technologies have provided improved quantification and Intraoperative optical coherence tomography (OCT) aids accurate decision-making during eye surgery by providing real-time imaging with simultaneous feedback features.
• An increase in the demand for optical coherence topography devices has led to a rise in competition among players. As a strategy to reach the larger masses, various players/manufacturers have lowered the costs of their devices, which in turn has led to the adoption of these devices by doctors in emerging economies along with developed countries. This factor is anticipated to drive demand for these devices in emerging economies in near future.

Request a Methodology@
https://www.futuremarketinsights.com/request-report-methodology/rep-gb-771

Competitive Landscape

TOPCON CORPORATION, ZEISS International, Ellex, Quantel Medical, NIDEK CO., LTD., HAAG-STREIT GROUP, Halma plc, Coburn Technologies Inc., Kowa Company Ltd. are some of the key companies profiled in the full version of the report.

Major competitors in the ophthalmic diagnostic equipment market are concentrating their efforts on expanding their worldwide and regional footprints through strategic acquisitions and mergers, as well as operational growth.

Companies in the ophthalmic diagnostic equipment market are following new product innovations and launches, regulatory approvals, and acquisitions as the key strategies. Key players are focusing on the development of advanced and cost-effective products and establishing distribution agreements to increase geographic reach, especially in the Asia Pacific region. Moreover, companies are targeting Asia region by establishing manufacturing units in order to reduce manufacturing costs.

More Insights into Ophthalmic Diagnostic Equipment Market

The United States is anticipated to rule the ophthalmic diagnostic equipment market accounting for over 89.2% of the North American region. Owing to the increased prevalence of refractive error disorders, the increased number of eye condition awareness programs, and the increased use of superior diagnostic technology are all contributing to this increase.

Germany accounted for approximately 28.6% of the Western Europe market in 2021. According to Eurostat one of the most common surgical procedures in Europe is cataract surgery. The rising number of cataract operations has had a significant influence on the ophthalmic industry, resulting in increased demand for cataract surgery equipment and medications.

China accounted for about 40.4% of the APEJ region in 2021. Factors such as the increasing number of people belonging to the older population that suffer primarily from poor eyesight and other eye-related diseases such as glaucoma and cataract contributed to market growth in this region.

India accounted for a 13.1% market share of APEJ in 2021 and is expected to show a similar trend in the coming years also. In India, ophthalmology-related disorders are on the rise. In India, almost 5 million cataract procedures are conducted every year. The bulk of these operations includes the implantation of intraocular lenses.

Ask Our Analyst More about Report @
https://www.futuremarketinsights.com/ask-question/rep-gb-771

Ophthalmic Diagnostic Equipment Market by Category

By Product:

• Fundus Cameras
• Retinal Ultrasound Imaging Systems
• Refractors
• Slit Lamps
• Perimeters
• Ophthalmoscopes
• Tonometer
• Optical Coherence Tomography (OCT)
• Corneal Topography Systems

By End user:

• Hospitals
• Clinics
• Ambulatory Surgical Centers

By Region:

• North America
• Latin America
• Western Europe
• Eastern Europe
• AEJ
• Japan
• Middle East and Africa (MEA)

Read Related Reports:

https://vocal.media/stories/liquid-biopsy-market-2022-scope-of-current-and-future-industry-2031
https://degentevakana.com/blogs/view/118096
https://degentevakana.com/blogs/view/118100
https://vocal.media/stories/dental-imaging-equipment-market-2022-scope-of-current-and-future-industry-2030

About FMI                     

Future Market Insights (ESOMAR certified market research organization and a member of Greater New York Chamber of Commerce) provides in-depth insights into governing factors elevating the demand in the market. It discloses opportunities that will favor the market growth in various segments on the basis of Source, Application, Sales Channel and End Use over the next 10-years.

Contact:                                        

Future Market Insights Inc.
Christiana Corporate, 200 Continental Drive,
Suite 401, Newark, Delaware – 19713, USA
T: +1-845-579-5705
Report: https://www.futuremarketinsights.com/reports/ophthalmic-diagnostic-equipment-market
For Sales Enquiries: sales@futuremarketinsights.com
Browse latest Market Reports: https://www.futuremarketinsights.com/reports
LinkedIn| Twitter| Blogs 

The global automated suturing devices market is expected to secure US$ 6.2 Billion while displaying a CAGR of 7.46% during the forecast period of 2022-2032. The expansion of the market can be attributed to the growing prevalence of chronic disorders and the increasing preference for minimally invasive surgeries. From 2017 to 2021, the market flourished at a CAGR of 7.2%.

Data Points	Key Statistics
Expected Market Value (2022)	US$ 3.02 Billion
Anticipated Forecast Value (2032)	US$ 6.2 Billion
Projected Growth Rate (2022-2032)	7.46%

Manufacturers are taking various initiatives to launch new products in the market. In 2021, Genesis MedTech inked an agreement with LivsMed for enhancing sales and distribution of the ArtiSential ™ line of products in China and Singapore. The ArtiSential ™ line is a series of articulating laparoscopic instruments that aim to offer the user fully articulating, wristed motion during laparoscopic surgery. In 2018, Ethicon US, LLC, rolled out a range of automated surgical suturing devices like ECHELON FLEX GST System, HARMONIC HD 1000i, 3 STRATAFIX Knotless Tissue Control Device, and others, with an aim to offer better suturing for bariatric surgeries.

Get Sample PDF@
https://www.futuremarketinsights.com/reports/sample/rep-gb-579

With the growing adoption of bariatric surgery as obesity prevalence increases, the market is projected to benefit the market during the forecast period. According to a report published in the International Journal of Environmental Research and Public Health in October 2019, in India, the prevalence of overweight, hypertension, obesity, and diabetes was 14.6%, 3.4%, 5.2%, and 7.1%, respectively. Further, in 2019, more than 30% of both male and female adults in the U.S reported themselves as obese.

Key Takeaways from the Market Study

• By product, reusable automated suturing devices to accumulate maximum revenue in 2022, at 49%
• Hospitals to retain top spot with regard to end user, capturing 56% of global market share in 2021
• North America to experience fastest growth amongst all regions, clocking a CAGR of 7.5% until 2032
• 1/3^rd of automated suturing devices to be deployed across Europe in 2022 and beyond
• APEJ to be the 2^nd fastest growing market for automated suturing devices, registering a 6.5% CAGR
• As of 2022, global automated suturing devices market revenue to surpass US$ 3 Billion

Speak to our Research Expert@
https://www.futuremarketinsights.com/ask-question/rep-gb-579

Competition Analysis

Key players in the global automated suturing devices market include Medtronic PLC, Boston Scientific, C.R. Bard Inc., Apollo Endosurgery, Endo Evolution LLC, LSI Solutions Inc., and SuturTek Inc.

Recent Developments in the Industry Include:

• In April 2021, Medtronic announced its partnership with Surgical Theater, a startup that markets a Surgery Rehearsal Platform. With the initiative, the companies focused to integrate SynAR’s augmented reality of Surgical Theater with Medtronic’s StealthStation S8 surgical navigation system. In addition, Medtronic is likely to allow surgeons to increase their outputs by providing ingenious technologies to them
• In January 2022, Endomina, an endoscopic medical suture device developed an Endo Tools Therapeutics, was approved by the United States Food and Drug Administration for endoscopic placement of sutures in the gastrointestinal tract in the adult population.

More Valuable Insights

Future Market Insights, in its new offering, presents an unbiased analysis of the global automated suturing devices market, presenting a historical analysis from 2017 to 2021 and forecast statistics for the period of 2022-2032.

The study reveals essential insights on the basis of Products (Reusable Automated Suturing Devices, Disposable Automated Suturing Devices), Applications (Minimally Invasive Surgeries, Open Surgeries, Trauma Cases), by End Use (Hospitals, Clinics, Ambulatory Surgical Centers), & Region (North America, Europe, Asia Pacific, Middle East & Africa, and Latin America).

Buy Now/Purchase:
https://www.futuremarketinsights.com/checkout/579

Read Related Reports:

https://vocal.media/stories/liquid-biopsy-market-2022-scope-of-current-and-future-industry-2031
https://degentevakana.com/blogs/view/118096
https://degentevakana.com/blogs/view/118100
https://vocal.media/stories/dental-imaging-equipment-market-2022-scope-of-current-and-future-industry-2030

About FMI                     

Future Market Insights (ESOMAR certified market research organization and a member of Greater New York Chamber of Commerce) provides in-depth insights into governing factors elevating the demand in the market. It discloses opportunities that will favor the market growth in various segments on the basis of Source, Application, Sales Channel and End Use over the next 10-years.

Contact:                                        

Future Market Insights Inc.
Christiana Corporate, 200 Continental Drive,
Suite 401, Newark, Delaware – 19713, USA
T: +1-845-579-5705
Report: https://www.futuremarketinsights.com/reports/automated-suturing-devices-market
For Sales Enquiries: sales@futuremarketinsights.com
Browse latest Market Reports: https://www.futuremarketinsights.com/reports
LinkedIn| Twitter| Blogs 

As per a recent market analysis by Future Market Insights (FMI), the pharmacovigilance market is poised to reach a valuation of US$ 6.28 million in 2022. Demand is projected to increase at a 13.1 % CAGR during the forecast period.

Attributes	Details
Pharmacovigilance Market CAGR (2022-2032)	13.1%
Pharmacovigilance Market Size (2022)	US$ 6.28 billion
Pharmacovigilance Market Size (2032)	US$ 24.32 billion

There is a rising demand for safer medications as a result of growing public knowledge of the negative effects of OTC medications. Due to the monitoring of easily available pharmaceuticals for potential adverse drug reactions, it is projected that this feature would increase the demand for pharmacovigilance.

Pharmacovigilance businesses can clearly benefit from outsourcing in terms of time constraints and the facilities that an outsourced service may provide. Outsourcing additionally enables companies to tailor services to their needs, hastening the evaluation process.

However, due to problems including the high risk associated with data security, the absence of worldwide regulatory harmonization, and the lack of data standardization for adverse event gathering, the pharmacovigilance market may experience a slowdown during the projected period.

Many clinical studies are currently predicted to be conducted to assess the efficacy of various pharmaceutical candidates, providing new growth prospects for UK-based pharmacovigilance solution providers.

Due to the market competitiveness for the release of innovative substances, there is a large demand for improved manufacturing processes, pharmacovigilance, clinical data management, streamlined R & D, and medical writing.

Get a Sample Copy of Report@
https://www.futuremarketinsights.com/reports/sample/rep-gb-1107

Key Takeaways

• The pharmacovigilance market is likely to have a CAGR of 13.1% during the forecast period.
• According to the phases of drug development, the phase IV stage generates around 75% of the revenue in 2021 for the pharmacovigilance market.
• North America holds the highest share of 30.0% in the global pharmacovigilance market.
• Based on the type of method, spontaneous reporting accounted for the biggest share of almost 30% in 2021.
• During the forecast period, the pharmacovigilance market in Asia Pacific is anticipated to expand at a CAGR of 12.1%.
• Based on service type, contract outsourcing dominates the pharmacovigilance market, with a share of 55%.
• The value of the pharmacovigilance market is expected to be US$ 24.32 billion by 2032.

Competitive Landscape:

While focusing on technology advancement, market participants are constantly creating safety services to promote the acceptance of pharmacovigilance services. Automation, artificial intelligence, and analytics have improved the efficiency of companies that provide pharmacovigilance services. Collaborations with leading pharmaceutical corporations are a crucial tactic for some pharmacovigilance market participants.

For any Queries Linked with the Report, Ask an Analyst@
https://www.futuremarketinsights.com/ask-question/rep-gb-1107

Key segments

By Phase of Drug Development:

• Preclinical Studies
• Phase I
• Phase II
• Phase III
• Phase IV

By Type of Methods:

• Spontaneous Reporting
• Intensified ADR Reporting
• Targeted Spontaneous Reporting
• Cohort Event Monitoring
• EHR Mining

By Service Type Provider:

• In-house Pharmacovigilance
• Contract Outsourcing

By Geography:

• North America
• Europe
• Asia-Pacific
• Latin America
• Middle East & Africa

Read Related Reports:

https://vocal.media/stories/liquid-biopsy-market-2022-scope-of-current-and-future-industry-2031
https://degentevakana.com/blogs/view/118096
https://degentevakana.com/blogs/view/118100
https://vocal.media/stories/dental-imaging-equipment-market-2022-scope-of-current-and-future-industry-2030

About FMI                     

Future Market Insights (ESOMAR certified market research organization and a member of Greater New York Chamber of Commerce) provides in-depth insights into governing factors elevating the demand in the market. It discloses opportunities that will favor the market growth in various segments on the basis of Source, Application, Sales Channel and End Use over the next 10-years.

Contact:                                        

Future Market Insights Inc.
Christiana Corporate, 200 Continental Drive,
Suite 401, Newark, Delaware – 19713, USA
T: +1-845-579-5705
Report: https://www.futuremarketinsights.com/reports/pharmacovigilance-market
For Sales Enquiries: sales@futuremarketinsights.com
Browse latest Market Reports: https://www.futuremarketinsights.com/reports
LinkedIn| Twitter| Blogs 

The global excimer and femtosecond ophthalmic lasers market is projected to rise at a robust pace of 8.0% CAGR over the assessment years from 2022 to 2032. The global market reached US$ 1.02 Bn in 2021 and is expected to touch a valuation of US$ 1.18 Bn by the end of 2022. The global market is anticipated to exceed a valuation of US$ 2.41 Bn by 2032.

Attribute	Key Statistics
Excimer and Femtosecond Ophthalmic Lasers Market Base Value (2021)	US$ 1.02 Bn
Estimated Market Value (2022)	US$ 1.18 Bn
Projected Market Value (2032)	US$ 2.41 Bn
Value-based CAGR of (2022-2032)	8.0%
Market share of Top 5 countries	56.5%

The growth in the global excimer and femtosecond ophthalmic lasers market is attributed to the increasing prevalence of eye diseases across the world and the surging adoption of ophthalmic lasers, the overall sales of excimer and femtosecond ophthalmic lasers are projected to rise.

An excimer laser is known as a form of ultraviolet laser which is commonly utilized in ophthalmic surgeries. Excimer laser photorefractive keratectomy and excimer laser in-situ keratomileusis (LASIK) are some of the most common procedures conducted using a laser which is used to rectify refractive errors of the eye, as excimer laser alters the refractive state of the eye by removing tissue from the anterior cornea.

On the basis of application, the refractive surgeries segment dominated the global Excimer and Femtosecond Ophthalmic Lasers Market with a total value share of nearly 69% in 2021.

Get a Sample Copy of the Report @
https://www.futuremarketinsights.com/reports/sample/rep-gb-1717

The excimer and femtosecond ophthalmic lasers are prominently used in surgical care for treating numerous eye disorders on account of their safe, precise, and accurate nature. Attributing to such attractive benefits and technological advancements, excimer and femtosecond ophthalmic lasers have the potential to become the gold standard of eye surgeries.

The increasing prevalence of multiple eye disorders such as glaucoma, macular degeneration, and diabetic retinopathy along with a surge in the number of eye surgeries performed worldwide is expected to bolster the growth of the Excimer and Femtosecond Ophthalmic Lasers Market during the assessment period.

Key Takeaways

• An increase in the opening of ophthalmology clinics and hospitals in many nations all over the world is expected to propel growth in the market. Due to the rise in the number of elderly people visiting ophthalmology clinics and hospitals as well as the large numbers of diabetic people who have eye disease or are at risk of developing it. These aforementioned factors are anticipated to grow femtosecond and excimer ophthalmic laser market growth during the next ten years.
• The government and several other regulatory bodies are meticulously working in order to make eye care services a crucial part of universal health coverage and address the increasing impact of vision loss on sustainable development. This is expected to create lucrative growth prospects within the global excimer and femtosecond laser market.
• In order to provide ophthalmologists with some of the best equipment possible to efficiently perform delicate eye procedures, ophthalmic laser manufacturers are constantly improving their laser systems.
• In comparison to manual surgery, Femtosecond laser cutting is done with greater precision and accuracy. Growth in the global excimer & femtosecond ophthalmic lasers market is mainly driven by the increasing diabetic and aging population globally. This increase is resulting in a rise in the number of common ophthalmic disorders such as cataracts, glaucoma, etc.
• The surge in the prevalence of age-related macular degeneration (AMD), glaucoma, cataract, diabetic retinopathy, and presbyopia require surgical correction to restore normal vision. Therefore, the increased aging and diabetic population is a major factor expected to fuel the growth of the global Excimer and Femtosecond Ophthalmic Lasers Market over the forecast period.

Competitive Landscape

The prominent market players in the healthcare sector are utilizing FLACS, or femtosecond laser-aided cataract surgery, as a safe and efficient therapy option for elderly patients, which is rapidly gaining ground. Hand-held surgical instruments in several procedures such as cataract fragmentation, anterior capsulotomy, and corneal incision are being drastically replaced by more efficient lasers resulting in increased accuracy and precision.

Key Companies Profiled: –

Medtronic Public Limited Company, Boston Scientific Corp, St Jude Medical LLC and Nevro Corp, Nuvectra Corporation and Stimwave, Neurosigma Inc., Synapse Biomedical Inc., Abbott Laboratories, Beijing PINS Medical Co., Ltd, Cirtec Medical Corporation, Gimer Medical, Bluewind Medical, Bioinduction, Greatbatch, Inc., Saluda Medical Pty Ltd.

Before Buying, Visit for Customization @
https://www.futuremarketinsights.com/customization-available/rep-gb-1717

Excimer and Femtosecond Ophthalmic Lasers Market Segments

Product:

• Excimer Laser
• Femtosecond Laser

Application:

• Refractive Surgery
• Cataract Surgery
• Capsulotomy
• Trabeculoplasty
• Diagnosis

End User:

• Hospitals
• Ambulatory Surgical Centers
• Ophthalmology Clinics

More Insights into the Excimer and Femtosecond Ophthalmic Lasers Market

The U.S. is expected to dominate the global excimer and femtosecond ophthalmic lasers market as it accounted for more around 81.8% of the North American Excimer and Femtosecond Ophthalmic Lasers Market in 2021 and it is poised to grow at a robust pace during the next ten years.

Read Related Reports:

https://vocal.media/stories/liquid-biopsy-market-2022-scope-of-current-and-future-industry-2031
https://degentevakana.com/blogs/view/118096
https://degentevakana.com/blogs/view/118100
https://vocal.media/stories/dental-imaging-equipment-market-2022-scope-of-current-and-future-industry-2030

About FMI                     

Future Market Insights (ESOMAR certified market research organization and a member of Greater New York Chamber of Commerce) provides in-depth insights into governing factors elevating the demand in the market. It discloses opportunities that will favor the market growth in various segments on the basis of Source, Application, Sales Channel and End Use over the next 10-years.

Contact:                                        

Future Market Insights Inc.
Christiana Corporate, 200 Continental Drive,
Suite 401, Newark, Delaware – 19713, USA
T: +1-845-579-5705
Report: https://www.futuremarketinsights.com/reports/excimer-femtosecond-ophthalmic-lasers-market
For Sales Enquiries: sales@futuremarketinsights.com
Browse latest Market Reports: https://www.futuremarketinsights.com/reports
LinkedIn| Twitter| Blogs